Syneos Health, Inc. (SYNH) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Diagnostics & Research Branche. Der Hauptsitz des Unternehmens ist in Morrisville, NC, United States. Der aktuelle CEO ist Michelle Keefe.
SYNH hat IPO-Datum 2014-11-07, 28,768 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $4.46B.
Syneos Health, Inc. is a global biopharmaceutical outsourcing solutions provider headquartered in Morrisville, North Carolina, serving clients across North America, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. The company operates through two primary segments: Clinical Solutions, which offers comprehensive development services for diagnostics, drugs, biologics, devices, and digital therapeutics across Phase I to IV clinical trials, including regulatory consulting, patient recruitment, clinical monitoring, and trial diversity support; and Commercial Solutions, which provides commercialization services including deployment strategies, communications solutions such as public relations and medical communications, and consulting services to pharmaceutical, biotechnology, and healthcare companies. With a history of innovation in the biopharmaceutical services industry, Syneos Health has established itself as a key partner for companies navigating drug development and market commercialization.
